Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis”

5,009 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,009 results

Post-approval studies (Phase 4)UnknownNCT03359746
What this trial is testing

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Who this might be right for
Hepatitis C
King Faisal Specialist Hospital & Research Center 40
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT00039962
What this trial is testing

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Testing effectiveness (Phase 2)Study completedNCT01464827
What this trial is testing

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1
AbbVie (prior sponsor, Abbott) 580
Post-approval studies (Phase 4)Study completedNCT02058173
What this trial is testing

"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"

Who this might be right for
Hepatitis C Virus
Shiraz University of Medical Sciences 10
Not applicableUnknownNCT04136405
What this trial is testing

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso

Who this might be right for
Hepatitis C Virus Infection, Past or PresentChronic Hepatitis c
ANRS, Emerging Infectious Diseases 3,300
Not applicableUnknownNCT03865966
What this trial is testing

Hepatitis B Virus Infection After Liver Transplantation in Children

Who this might be right for
Hepatitis B Infection
Qiu Li 100
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Not applicableStudy completedNCT05868005
What this trial is testing

Delivering a Multi-disease Screening Tool to Migrant Populations

Who this might be right for
HivHepatitis BHepatitis C+7 more
Barcelona Institute for Global Health 980
Testing effectiveness (Phase 2)Study completedNCT01508156
What this trial is testing

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 130
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Not applicableUnknownNCT05991531
What this trial is testing

Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B Patients
Beijing Friendship Hospital 100
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Post-approval studies (Phase 4)UnknownNCT01056172
What this trial is testing

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Who this might be right for
Chronic Hepatitis C
Pusan National University Yangsan Hospital 164
Large-scale testing (Phase 3)Study completedNCT01014845
What this trial is testing

Clinical Trial of Recombinant Hepatitis E Vaccine

Who this might be right for
Hepatitis E
Xiamen University 112,604
Testing effectiveness (Phase 2)Study completedNCT00511095
What this trial is testing

Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 207
Not applicableStudy completedNCT03088995
What this trial is testing

Pilot Study of HIV and Hepatitis B and C Screening in Surgery

Who this might be right for
HIV InfectionsHepatitis BHepatitis C
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03489239
What this trial is testing

Entecavir to TAF Switch

Who this might be right for
Hepatitis B
Thomas Jefferson University 27
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Next Page